Japan Long-term Safety for Tiotropium Plus Olodaterol

NCT01536262 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

122

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Tiotropium + Olodaterol
DEVICE: Respimat
DRUG: Tiotropium + Olodaterol
DRUG: Olodaterol
DEVICE: Respimat
DEVICE: Respimat

Sponsor

Boehringer Ingelheim